FORMULATION AND EVALUATION OF TRANSDERMAL PATCHES OF ATENOLOL

Uttam Budhathoki, Kshitij Gartoulla, Shailendra Shakya

Abstract


This study was carried out to develop matrix based transdermal patches containing Atenolol. A 2 factors (HPMC (hydroxyl propyl methyl cellulose) K4M & PVP (Polyvinyl Pyrolidone) 3 level (23) factorial design was done using Design Expert® which gave 13 experiments. The patches were prepared by Solvent casting method. Propylene glycol (3%) and Tween 80 (6%) were used as plasticizer and permeation enhancer respectively. Physicochemical characteristics and In-Vitro permeation study of formulated transdermal patches were carried out. Contour plot suggested 770 mg of PVP and 265 mg of HPMC K4M in Optimized formulation. 


References


Ibrahim SA., 2014. Spray-on transdermal drug delivery system. Expert opin Drug Deliv. 17 : 1-11.

Sun YM., Huang JJ., Lin FC., Lai JY., 1997. Composite poly (2- hydroxyethyl Methacrylate) membranes as rate-controlling barriers for transdermal applications. Biomaterial. 18(7) : 527-533.

Ahmed A., Karki NK., Charde RM., Charde MS., 2011. Transdermal drug delivery systems:an overview. Int J of Biomed & Adv Res. 2(1) : 38-56.

Jhawat VC., Saini V., Kamboj S., Maggon N., 2013. Transdermal drug delivery systems: Approaches and Advancements in Drug Absorption through skin. Int J Pharm Sci Rev Res. 20(1) : 47-56.

Saroha K., Yadav B., Sharma B., 2011. Transdermal patch: a discrete dosage form, Int J Curr Pharm Res. 3(3) : 98-108.

Jhawat VC., Saini V., Kamboj S., Maggon N., 2013. Transdermal drug delivery systems: approaches and advancements in drug absorption through skin. Int J Pharm Sci Rev Res. 20(1) : 47-56.

Premjeet S., Bilandi A., Sahil K., Akanksha M., 2011 Transdermal drug delivery system (patches), applications in present scenario: Int J Res Pharm Chem. 1(4) : 1139-1151.

Chein YW., 1987. Transdermal controlled systemic medication. Marcel Dekkar Inc, New York, USA. pp. 159-176.

Aulton ME., 2002. Pharmaceutics: The science of dosage form design. 2nd ed. Churchill Livingston, London, UK. pp. 499-533.

Sharma N, Parashar B., Sharma S., Mahajan U., 2012. Blooming pharma industry with transdermal drug delivery system, Indo Global J Pharm Sci. 2(3) : 262-278.

Muller B., Kasper M., Surber C., Imanidis G., 2003. Permeation, metabolism and site of action concentration of nicotinic acid derivatives in human skin: correllation with topical pharmacological effect. Eur J Pharm Sci. 20(2) : 181-195.

Finnin BC., Morgan TM., 1999. Transdermal penetration enhancers: applications, limitations, and potential. J Pharm Sci, 88(10) : 955–958.

Funke AP., Schiller R., Motzkus HW., Günther C., Müller RH., Lipp R., 2002. Transdermal delivery of highly lipophilic drugs: In vitro fluxes of antiestrogens, permeation enhancers and solvents from liquid formulations. Pharm Res. 19(5) : 661-668.

Taylor LJ., Lee RS., Long M., Rawlings AV., Tubek J., Whitehead L., Moss GP., 2002. Effect of occlusion on the percutaneous penetration of linoleic acid and glycerol. Int J Pharm. 249(1-2) : 157-164.

Ghosh B., Reddy LH., 2001. Effect of physicochemical parameters on skin permeability of antihypertensive. Indian J Exp Biol. 39(7) : 710-714.

Jain GK., Kaul JL., Agrawal SS., 1993. In vitro transdermal delivery of atenolol using mouse and guinea pig. Indian J Exp Biol, 31 (8): 691-693.

Bangale GS., Rathinaraj BS., Rajesh KS., Shinde GV., Umalkar DG., Rajveer CH., Kumaraswamy D., Panicker PS., 2010. Design and evaluation of transdermal films of Atenolol. J Chem Pharm Res, 2010. 2(3) : 593-604.

Gupta JRD., Irchhiaya R., Garud N., Tripathi P., Dubey P., Patel JR., 2009. Formulation and evaluation of matrix type transdermal patches of glibenclamide. Int J Pharm Sci Drug Res. 1(1): 46-50.

Darwhekar G., Jain DK., Patidar VK., 2011. Formulation and evaluation of transdermal drug delivery system of clopidogrel bisulphate. Asian J Pharm life Sci. 1(3) : 269-278.

De PK., Paul J., Dey SK., Dinda SC., Rakshit S., 2011. Formulation, physic-chemical characterization and release kinetic study of antihypertensive transdermal patches. Der Pharm Sin. 2(5) : 98-109.

Patel HV., Bhatt J., Patel NK., 2013. Design and development of transdermal drug delivery for anti-hypertensive drug using different polymeric system. Int J Pharm Chem Sci. 2(2) : 942-949.

Ramesh Y., Anjana AKM., Manjula DB., Sankeerthana K., Sri LP., Vasanthi A., 2015. Formulation and evaluation of atenolol transdermal patches. Creative J Pharm Res. 1(2) : 55-65.




DOI: http://dx.doi.org/10.14499/indonesianjpharm27iss4pp%25p

Refbacks

  • There are currently no refbacks.


Indonesian J Pharm indexed by: